Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’sdisease and erectile dysfunction: results from a prospective randomized trial.

Int J Androl. 2012 Apr;35(2):190-5. doi: 10.1111/j.1365-2605.2011.01226.x. Epub 2011 Nov 15. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial. Palmieri A, Imbimbo C, Creta M, Verze P, Fusco F, Mirone V. Source Department of Urology, University Federico II of Naples, Naples, Italy. Abstract Extracorporeal shock wave therapy improves erectile function in patients with Peyronie’s disease.…

Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: long-term results.

Arch Ital Urol Androl. 2010 Jun;82(2):128-33. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: long-term results. De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V. Source Policlinico Umberto I, Dipartimento Urologia “U. Bracci”, Sapienza Università di Roma, Italy. Erratum in Arch Ital Urol Androl. 2010 Sep;82(3):III. De Berardinis, Ettore [added]; Antonini, Gabriele [added]; Giovannone, Riccardo [added]; Gentile, Vincenzo [added]. Abstract PURPOSE: Controversial data…

Preliminary findings from a new animal model for Peyronie’s disease involving extracorporeal shock waves.

BJU Int. 2009 Apr;103(8):1104-6. doi: 10.1111/j.1464-410X.2008.08173.x. Epub 2008 Nov 18. Preliminary findings from a new animal model for Peyronie’s disease involving extracorporeal shock waves. Andrade E, Cortez I, Claro J, Pompeu E, Leite K, Paranhos M, Borra P, Lucon AM, Srougi M. Source Department of Urology, University of Sao Paulo, Sao Paulo, Brazil. enricoandrade@uol.com.br Abstract OBJECTIVE: To develop an experimental model in rabbits to analyse the efficiency of extracorporeal shock wave therapy (ESWT) for…

Evaluation of extracorporeal shock wave therapy in Peyronie’s disease.

Urology. 2002 Nov;60(5):795-9; discussion 799-800. Evaluation of extracorporeal shock wave therapy in Peyronie’s disease. Manikandan R, Islam W, Srinivasan V, Evans CM. Source Department of Urology, Glan Clwyd Hospital, Rhyl, United Kingdom. Abstract OBJECTIVES: To evaluate the results of extracorporeal shock wave therapy (ESWT) in patients with Peyronie’s disease. METHODS: This study included 42 patients (mean age 55.4 years, range 32 to 72, SD 9.92) with Peyronie’s disease. The mean duration of diseasewas…

Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: experience with standard lithotriptor (siemens-multiline).

Urology. 2002 May;59(5):657-61. Extracorporeal shock wave therapy in the treatment of Peyronie’s disease: experience with standard lithotriptor (siemens-multiline). Lebret T, Loison G, Hervé JM, Mc Eleny KR, Lugagne PM, Yonneau L, Orsoni JL, Saporta F, Butreau M, Botto H. Source Department of Urology, Hôpital Foch, Suresnes, France. Abstract OBJECTIVES: To assess in a prospective study whether extracorporeal shock wave therapy (ESWT) using a standard radioscopic location lithotriptor is effective in the treatment of Peyronie’s disease. METHODS: Fifty-four patients were included…

Extracorporeal shock wave therapy in the management of Peyronie’s disease: initial experience.

BJU Int. 2000 Sep;86(4):466-8. Extracorporeal shock wave therapy in the management of Peyronie’s disease: initial experience. Husain J, Lynn NN, Jones DK, Collins GN, O’Reilly PH. Source Department of Urology, Stepping Hill Hospital, Stockport, UK. Abstract OBJECTIVE: To evaluate prospectively the efficacy of extracorporeal shock wave therapy (ESWT) as a conservative treatment for Peyronie’s disease. PATIENTS AND METHODS: After obtaining ethical committee approval, 37 patients with Peyronie’s disease were treated using ESWT. Beforetreatment the degree of…

Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis.

Arch Ital Urol Nefrol Androl. 1989 Dec;61(4):417-22. Possibility of using the piezoelectric lithotriptor in the treatment of severe cavernous fibrosis. [Article in Italian] Bellorofonte C, Ruoppolo M, Tura M, Zaatar C, Tombolini P, Menchini Fabris GF. Abstract The treatment of serious cavernous corpora fibrosis due to priapism, a prosthesis explantation, iatrogenic causes, or Peyronie’s disease, is by now still uncertain. Therefore we tried, when medical and…

Extracorporeal shock wave therapy for Peyronie’s disease: exploratory meta-analysis of clinical trials.

  J Urol. 2004 Feb;171(2 Pt 1):740-5.   Extracorporeal shock wave therapy for Peyronie’s disease: exploratory meta-analysis of clinical trials.   Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W.   Source   Department of Urology, Justus Leibig University, Giessen, Germany.   Abstract   PURPOSE:   Extracorporeal shock wave therapy (ESWT) for the treatment of Peyronie’s disease is still controversial. This exploratory meta-analysis of published studies in the international literature investigates its therapeutic…

DOES LOW-INTENSITY EXTRACORPOREAL SHOCK WAVE THERAPY HAVE A PHYSIOLOGIC EFFECT ON ERECTILE FUNCTION? SHORT-TERM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY

The Journal of Urology Volume 187, Issue 4, Supplement , Page e606, April 2012 DOES LOW-INTENSITY EXTRACORPOREAL SHOCK WAVE THERAPY HAVE A PHYSIOLOGIC EFFECT ON ERECTILE FUNCTION? SHORT-TERM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY Vardi, Appel, Kilchevsky, Gruenwald   Affiliations ·Haifa, Israel INTRODUCTION AND OBJECTIVES Low-intensity extracorporeal shockwave therapy (LI-ESWT) is currently under investigation regarding its…

Potential of adipose-derived stem cells for treatment of erectile dysfunction.

J Sex Med. 2009 Mar;6 Suppl 3:320-7. doi: 10.1111/j.1743-6109.2008.01190.x. Potential of adipose-derived stem cells for treatment of erectile dysfunction. Lin G, Banie L, Ning H, Bella AJ, Lin CS, Lue TF. Source School of Medicine, Department of Urology, University of California-Knuppe Molecular Urology Laboratory, San Francisco, CA 94143-0738, USA. glin@urology.ucsf.edu Abstract INTRODUCTION: Adipose-derived stem cells (ADSCs) are a somatic stem cell…